Gene · 3455
Papers3,850
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,850
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Host Genetic Susceptibility and Antiviral Immunity Shape the Pathogenesis and Outcomes of Herpes Simplex Encephalitis. | Biology (Basel) | 2026 | 42792593 | PubTator, text mining | PubMed |
| Functional divergence of the Bhanja virus NSs protein modulates interferon antagonism and viral fitness across divergent lineages. | PLoS Pathog | 2026 | 42784634 | PubTator, text mining | PubMed |
| Functional diversity of natural human IFNB1 variants in innate immunity. | Sci Adv | 2026 | 42758835 | PubTator, text mining | PubMed |
| TLR7/9 and type I interferon signaling reprogram neutrophil NET responses and impair antibacterial defense in systemic lupus erythematosus. | Cell Press Blue | 2026 | 42746563 | PubTator, text mining | PubMed |
| Integrated Inflammatory, Thrombo-Inflammatory, Redox and Soluble IFNAR2 Profiling During Hospitalization for COVID-19: An Exploratory Observational Cohort Study. | J Clin Med | 2026 | 42739730 | PubTator, text mining | PubMed |
| Transcriptomic profiling reveals immune signatures associated with potential COVID-19 susceptibility and a predictive framework in a Chinese cohort. | Front Immunol | 2026 | 42698521 | PubTator, text mining | PubMed |
| Regulators of interferon-responsive microglia uncovered by Genome-wide CRISPRi screening. | NPJ Dement | 2026 | 42694111 | PubTator, text mining | PubMed |
| IL-17A Restrains Antiviral Immunity to Promote Chikungunya Virus Infection and Pathogenesis in the Heart. | bioRxiv | 2026 | 42620426 | PubTator, text mining | PubMed |
| Developing and Characterizing a Murine Model of In Utero Transmission of Ebola Virus. | bioRxiv | 2026 | 42620007 | PubTator, text mining | PubMed |
| Disentangling Shared and Differential Genetic Architectures Between COVID-19 and Other Respiratory Disorders-A Genome-Wide Multi-Omics Framework. | Int J Mol Sci | 2026 | 42511876 | PubTator, text mining | PubMed |
| Optimized strategies for necroptosis induction and evaluation. | Methods Cell Biol | 2026 | 42442864 | PubTator, text mining | PubMed |
| GM-CSF downregulates type I IFN responses in glioblastoma-associated monocytes. | Exp Mol Med | 2026 | 42399654 | PubTator, text mining | PubMed |
| A yellow fever 17D and Usutu virus chimera with rationally designed mutations in the envelope protein is lethal in an Ifnar-/- mouse model. | Virol J | 2026 | 42393766 | PubTator, text mining | PubMed |
| ZIKV NS3 disrupts Nrf2-mediated antioxidant defense and drives vascular smooth muscle cell damage and vascular dysfunction. | Zool Res | 2026 | 42339736 | PubTator, text mining | PubMed |
| TLR7 in systemic lupus erythematosus: genetics and emerging therapies. | Nat Rev Rheumatol | 2026 | 42321474 | PubTator, text mining | PubMed |
| Innate immune-regulated sulfated glycosaminoglycans are associated with progeny respiratory syncytial virus retention at the cell surface in immortalized cell lines. | Virology | 2026 | 42242124 | PubTator, text mining | PubMed |
| Re Du Ning exerts anti-influenza activity by counteracting viral NS1-mediated suppression of host type I interferon signaling. | J Ethnopharmacol | 2026 | 42235715 | PubTator, text mining | PubMed |
| Expression of bluetongue virus core proteins VP2 and VP7 by bovine herpesvirus-4 confers protection against virulent challenge in a mouse model. | Vet Res | 2026 | 42210331 | PubTator, text mining | PubMed |
| Evolutionary Complexity of Primate Immune System Uncovered by the Extensive Phylogenomic Sampling. | Genome Biol Evol | 2026 | 41921952 | PubTator, text mining | PubMed |
| Interferon dynamics in deltaretroviruses: why HTLV-1 evades, but BLV responds. | Mol Biol Rep | 2026 | 41920397 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3455/papers